Page last updated: 2024-11-13

3,7-dioxolanosta-8,24-dien-26-oic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,7-dioxolanosta-8,24-dien-26-oic acid: isolated from the mushroom Ganoderma lucidum [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID46888220
CHEMBL ID1099224
MeSH IDM0588848
PubMed CID72787537
MeSH IDM0588848

Synonyms (9)

Synonym
173075-45-1
CHEMBL1099224
ganoderic acid dm
bdbm50104745
AKOS032948636
(z,6r)-2-methyl-6-[(5r,10s,13r,14r,17r)-4,4,10,13,14-pentamethyl-3,7-dioxo-2,5,6,11,12,15,16,17-octahydro-1h-cyclopenta[a]phenanthren-17-yl]hept-2-enoic acid
3,7-dioxolanosta-8,24-dien-26-oic acid
BCP16405
gaderic acid dm

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (23)

Assay IDTitleYearJournalArticle
AID353555Inhibition of 5-alpha-reductase in rat liver microsome assessed as conversion of [14C] testosterone to [14C] dihydrotestosterone2009Bioorganic & medicinal chemistry letters, Apr-15, Volume: 19, Issue:8
Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor.
AID1235935Cytotoxicity against human PC3 cells by MTT method2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and Their Inhibitory Effects on HMG-CoA Reductase and α-Glucosidase.
AID353564Cytotoxicity against mouse RAW264 cells assessed as viable cells at 25 uM after 3 days by WST1 assay2009Bioorganic & medicinal chemistry letters, Apr-15, Volume: 19, Issue:8
Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor.
AID1235933Inhibition of maltase in rat intestinal mucosa pre-incubated for 40 mins using maltose substrate2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and Their Inhibitory Effects on HMG-CoA Reductase and α-Glucosidase.
AID1551897Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability by WST-1 assay2019European journal of medicinal chemistry, Jul-15, Volume: 174Review of the molecular mechanisms of Ganoderma lucidum triterpenoids: Ganoderic acids A, C2, D, F, DM, X and Y.
AID353557Growth inhibition against testosterone-induced human LNCAP cell proliferation assessed as decrease in cell viability after 3 dayssby NR assay2009Bioorganic & medicinal chemistry letters, Apr-15, Volume: 19, Issue:8
Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor.
AID1235931Inhibition of alpha-glucosidase in rat intestinal mucosa pre-incubated for 40 mins using p-nitrophenyl-alpha-D-glucopyranoside substrate2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and Their Inhibitory Effects on HMG-CoA Reductase and α-Glucosidase.
AID1235929Inhibition of pig liver microsomes HMG-CoA reductase incubated for 5 mins in using HMG-CoA and NADPH by colorimetric method2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and Their Inhibitory Effects on HMG-CoA Reductase and α-Glucosidase.
AID1235932Inhibition of sucrase in rat intestinal mucosa pre-incubated for 40 mins using sucrose substrate2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and Their Inhibitory Effects on HMG-CoA Reductase and α-Glucosidase.
AID1551899Inhibition of calcitriol-induced formation of Sprague-Dawley rat osteoclasts by WST-1 assay2019European journal of medicinal chemistry, Jul-15, Volume: 174Review of the molecular mechanisms of Ganoderma lucidum triterpenoids: Ganoderic acids A, C2, D, F, DM, X and Y.
AID353562Inhibition of osteoclastogenesis in RANKL-stimulated mouse RAW264 cells at 25 uM after 3 days by TRAP assay2009Bioorganic & medicinal chemistry letters, Apr-15, Volume: 19, Issue:8
Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor.
AID1235934Cytotoxicity against human K562 cells by MTT method2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and Their Inhibitory Effects on HMG-CoA Reductase and α-Glucosidase.
AID711425Inhibition of rat microsomal 5-alpha reductase assessed as inhibition of conversion of [4-14C]testosterone to [4-14C] dihydrotestosterone after 10 mins2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Lanostanoids from fungi: a group of potential anticancer compounds.
AID353554Inhibition of DHT binding to human recombinant androgen receptor ligand binding domain at 15 uM by fluorescence polarization2009Bioorganic & medicinal chemistry letters, Apr-15, Volume: 19, Issue:8
Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor.
AID1235930Inhibition of Baker's yeast alpha-glucosidase2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and Their Inhibitory Effects on HMG-CoA Reductase and α-Glucosidase.
AID353559Antiproliferative activity against human PC3 cells at 12.5 to 50 uM after 3 days by NR assay2009Bioorganic & medicinal chemistry letters, Apr-15, Volume: 19, Issue:8
Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor.
AID1551898Inhibition of RANKL/tumour necrosis factor alpha-induced formation of osteoclasts (unknown origin) by tartrate-resistant acid phosphatase staining based assay2019European journal of medicinal chemistry, Jul-15, Volume: 174Review of the molecular mechanisms of Ganoderma lucidum triterpenoids: Ganoderic acids A, C2, D, F, DM, X and Y.
AID353563Cytotoxicity against mouse RAW264 cells assessed as cell number at 12.5 uM after 3 days by WST1 assay2009Bioorganic & medicinal chemistry letters, Apr-15, Volume: 19, Issue:8
Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor.
AID353556Growth inhibition of human LNCAP cells assessed as decrease in cell viability after 3 days by NR assay2009Bioorganic & medicinal chemistry letters, Apr-15, Volume: 19, Issue:8
Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor.
AID353561Inhibition of osteoclastogenesis in RANKL-stimulated mouse RAW264 cells at 12.5 uM after 3 days by TRAP assay2009Bioorganic & medicinal chemistry letters, Apr-15, Volume: 19, Issue:8
Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor.
AID479066Antiplasmodial activity against Plasmodium falciparum at 20 uM2010Journal of natural products, May-28, Volume: 73, Issue:5
Antiplasmodial lanostanes from the Ganoderma lucidum mushroom.
AID711441Cytotoxicity against human HeLa cells2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Lanostanoids from fungi: a group of potential anticancer compounds.
AID353558Growth inhibition against dihydrotestosterone-induced human LNCAP cell proliferation assessed as decrease in cell viability after 3 dayssby NR assay2009Bioorganic & medicinal chemistry letters, Apr-15, Volume: 19, Issue:8
Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's1 (9.09)29.6817
2010's7 (63.64)24.3611
2020's2 (18.18)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.84

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.84 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.84)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews2 (40.00%)6.00%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other3 (60.00%)84.16%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]